Loading organizations...
Fermentalg develops sustainable BioSolutions by harnessing the potential of aquatic microorganisms, particularly microalgae. The company’s core product involves cultivating microalgae through advanced biotechnological processes to extract valuable compounds like Omega-3 DHA. Their technical approach focuses on precision fermentation to produce natural ingredients that serve various markets, emphasizing ecological design and robust industrial production.
Pierre Calleja founded Fermentalg in 2009 in Libourne, France, driven by a visionary insight into the extraordinary capabilities of microalgae. He believed these microscopic organisms offered a pathway to creating sustainable ingredients, moving beyond traditional sources. This pioneering spirit from its inception allowed the company to evolve from a biotech startup into an established player in microalgae biotechnology.
Fermentalg’s BioSolutions cater to both human and animal health sectors, providing natural, reliable, and sustainable ingredients for nutrition and well-being. The company’s overarching mission is to transform nature’s wisdom into impactful solutions, aiming to improve global health while actively preserving biodiversity and fostering a more sustainable future for the planet.
Key people at Fermentalg.
Key people at Fermentalg.
Fermentalg has 1 tracked investment across 1 company. The latest tracked deal is $12.2M Series A in CarbonWorks in March 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 3, 2022 | CarbonWorks | $12.2M Series A | Aquiti Gestion, BNP Paribas Principal Investments, Bpifrance, Demeter | R Gion Nouvelle Aquitaine, Charles Chami |